Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer’s disease

PLoS Genetics

Volumn 13, Issue 7, 2017, Pages

  Lu, Qiongshi ^a,f   Powles, Ryan L ^a   Abdallah, Sarah ^b   Ou, Derek ^b   Wang, Qian ^a   Hu, Yiming ^a   Lu, Yisi ^b   Liu, Wei ^c   Li, Boyang ^a   Mukherjee, Shubhabrata ^d   Crane, Paul K ^d   Zhao, Hongyu ^a,e  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PEKING UNIVERSITY   (China)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e VA Cooperative Studies Program Coordinating Center   (United States)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EPIGENETICS; GENE FUNCTION; GENE LOCUS; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MATHEMATICAL COMPUTING; MOLECULAR GENETICS; MONOCYTE; ONSET AGE; PLEIOTROPY; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS; ANTIBODY SPECIFICITY; GENETIC DATABASE; GENETICS; HUMAN GENOME;

TRANSCRIPTOME;

ALZHEIMER DISEASE; DATABASES, GENETIC; EPIGENOMICS; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MOLECULAR SEQUENCE ANNOTATION; ORGAN SPECIFICITY; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTOME;

EID: 85026680407     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1006933     Document Type: Article

References (85)

1. Bernstein B.E., et al. An integrated encyclopedia of DNA elements in the human genome. Nature, 2012. 489(7414): p. 57–74. doi: 10.1038/nature11247 22955616
2. Kundaje A., et al. Integrative analysis of 111 reference human epigenomes. Nature, 2015. 518(7539): p. 317–330. doi: 10.1038/nature14248 25693563
3. Schaub M.A., et al. Linking disease associations with regulatory information in the human genome. Genome research, 2012. 22(9): p. 1748–1759. doi: 10.1101/gr.136127.111 22955986
4. Maurano M.T., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science, 2012. 337(6099): p. 1190–1195. doi: 10.1126/science.1222794 22955828
5. Kellis M., et al. Defining functional DNA elements in the human genome. Proc Natl Acad Sci U S A, 2014.
6. Lu Q., et al. Integrative Tissue-Specific Functional Annotations in the Human Genome Provide Novel Insights on Many Complex Traits and Improve Signal Prioritization in Genome Wide Association Studies. PLoS Genet, 2016. 12(4): p. e1005947. doi: 10.1371/journal.pgen.1005947 27058395
7. Myers A.J., Goate A.M., The genetics of late-onset Alzheimer's disease. Current opinion in neurology, 2001. 14(4): p. 433–440. 11470958
8. Lambert J.-C., et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nature genetics, 2013. 45(12): p. 1452–1458. doi: 10.1038/ng.2802 24162737
9. Raj T., et al. Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science, 2014. 344(6183): p. 519–523. doi: 10.1126/science.1249547 24786080
10. Heneka M.T., Golenbock D.T., Latz E., Innate immunity in Alzheimer's disease. Nat Immunol, 2015. 16(3): p. 229–236. doi: 10.1038/ni.3102 25689443
11. Heppner F.L., Ransohoff R.M., Becher B., Immune attack: the role of inflammation in Alzheimer disease. Nature Reviews Neuroscience, 2015. 16(6): p. 358–372. doi: 10.1038/nrn3880 25991443
12. Lu Q., et al. A Statistical Framework to Predict Functional Non-Coding Regions in the Human Genome Through Integrated Analysis of Annotation Data. Sci. Rep., 2015. 5.
13. Fischle W., Wang Y., Allis C.D., Binary switches and modification cassettes in histone biology and beyond. Nature, 2003. 425(6957): p. 475–479. doi: 10.1038/nature02017 14523437
14. Trynka G., et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nature genetics, 2013. 45(2): p. 124–130. doi: 10.1038/ng.2504 23263488
15. Wienholds E., Plasterk R.H., MicroRNA function in animal development. FEBS letters, 2005. 579(26): p. 5911–5922. doi: 10.1016/j.febslet.2005.07.070 16111679
16. Yanai I., et al. Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification. Bioinformatics, 2005. 21(5): p. 650–659. doi: 10.1093/bioinformatics/bti042 15388519
17. Ludwig N., et al. Distribution of miRNA expression across human tissues. Nucleic acids research, 2016. 44(8): p. 3865–3877. doi: 10.1093/nar/gkw116 26921406
18. Mattick J.S., The genetic signatures of noncoding RNAs. PLoS Genet, 2009. 5(4): p. e1000459. doi: 10.1371/journal.pgen.1000459 19390609
19. Derrien T., et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome research, 2012. 22(9): p. 1775–1789. doi: 10.1101/gr.132159.111 22955988
20. Bulger M., Groudine M., Enhancers: the abundance and function of regulatory sequences beyond promoters. Developmental biology, 2010. 339(2): p. 250–257. doi: 10.1016/j.ydbio.2009.11.035 20025863
21. Andersson R., et al. An atlas of active enhancers across human cell types and tissues. Nature, 2014. 507(7493): p. 455–461. doi: 10.1038/nature12787 24670763
22. Korn T., et al. IL-17 and Th17 Cells. Annual review of immunology, 2009. 27: p. 485–517. doi: 10.1146/annurev.immunol.021908.132710 19132915
23. Wilson C.B., Rowell E., Sekimata M., Epigenetic control of T-helper-cell differentiation. Nature Reviews Immunology, 2009. 9(2): p. 91–105. doi: 10.1038/nri2487 19151746
24. Dong C., Genetic controls of Th17 cell differentiation and plasticity. Experimental & molecular medicine, 2011. 43(1): p. 1–6.
25. Akimzhanov A.M., Yang X.O., Dong C., Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation. Journal of Biological Chemistry, 2007. 282(9): p. 5969–5972. doi: 10.1074/jbc.C600322200 17218320
26. Finucane H.K., et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nature Genetics, 2015.
27. Wood A.R., et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet, 2014. 46(11): p. 1173–86. doi: 10.1038/ng.3097 25282103
28. Group, S.S.S.S.Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). The Lancet, 1994. 344(8934): p. 1383–1389.
29. Simon-Sanchez J., et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nature genetics, 2009. 41(12): p. 1308–1312. doi: 10.1038/ng.487 19915575
30. Hardy J., et al. Pathways to Alzheimer's disease. Journal of internal medicine, 2014. 275(3): p. 296–303. doi: 10.1111/joim.12192 24749173
31. Jones L., et al. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PloS one, 2010. 5(11): p. e13950. doi: 10.1371/journal.pone.0013950 21085570
32. Kircher M., et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nature genetics, 2014. 46(3): p. 310–315. doi: 10.1038/ng.2892 24487276
33. Ritchie G.R., et al. Functional annotation of noncoding sequence variants. Nature methods, 2014. 11(3): p. 294–296. doi: 10.1038/nmeth.2832 24487584
34. Ionita-Laza I., et al. A spectral approach integrating functional genomic annotations for coding and noncoding variants. Nature genetics, 2016. 48(2): p. 214–220. doi: 10.1038/ng.3477 26727659
35. Anttila V., et al. Analysis of shared heritability in common disorders of the brain. bioRxiv, 2016: p. 048991.
36. Ridge P.G., et al. Alzheimer’s disease: analyzing the missing heritability. PloS one, 2013. 8(11): p. e79771. doi: 10.1371/journal.pone.0079771 24244562
37. Martinelli-Boneschi F., et al. Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors. Neurobiology of aging, 2013. 34(6): p. 1711. e7–1711. e13.
38. Esposito F., et al. A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity. Annals of neurology, 2015. 78(1): p. 115–127. doi: 10.1002/ana.24429 25914168
39. Turner S.T., et al. Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker. Hypertension, 2012. 59(6): p. 1204–1211. doi: 10.1161/HYP.0b013e31825b30f8 22566498
40. Mick E., et al. Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 2010. 49(9): p. 898–905. e3.
41. Kondapalli K.C., et al. Functional evaluation of autism-associated mutations in NHE9. Nature communications, 2013. 4.
42. Chalasani N., et al. Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease. Gastroenterology, 2010. 139(5): p. 1567–1576. e6. doi: 10.1053/j.gastro.2010.07.057 20708005
43. Matarín M., et al. A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release. The Lancet Neurology, 2007. 6(5): p. 414–420. doi: 10.1016/S1474-4422(07)70081-9 17434096
44. Yashin A.I., et al. Joint influence of small-effect genetic variants on human longevity. Aging, 2010. 2(9): p. 612–620. doi: 10.18632/aging.100191 20834067
45. Okada Y., et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature, 2014. 506(7488): p. 376–381. doi: 10.1038/nature12873 24390342
46. Martin J.-E., et al. A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. Human molecular genetics, 2013. 22(19): p. 4021–4029. doi: 10.1093/hmg/ddt248 23740937
47. Day F.R., et al. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nat Genet, 2015. 47(11): p. 1294–303. doi: 10.1038/ng.3412 26414677
48. Hart A.B., et al. Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13). PloS one, 2012. 7(8): p. e42646. doi: 10.1371/journal.pone.0042646 22952603
49. Potkin S.G., et al. Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PloS one, 2009. 4(8): p. e6501. doi: 10.1371/journal.pone.0006501 19668339
50. Jun G., et al. A novel Alzheimer disease locus located near the gene encoding tau protein. Molecular psychiatry, 2015.
51. Ashok A., et al. Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9. Neurobiology of Disease, 2016. 95: p. 179–193. doi: 10.1016/j.nbd.2016.07.013 27431094
52. Severini C., et al. Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity. Scientific reports, 2015. 5.
53. Stoothoff W.H., et al. Axin negatively affects tau phosphorylation by glycogen synthase kinase 3β. Journal of neurochemistry, 2002. 83(4): p. 904–913. 12421363
54. Nalls M.A., et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nature genetics, 2014. 46(9): p. 989–993. doi: 10.1038/ng.3043 25064009
55. Purcell S.M., et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 2009. 460(7256): p. 748–752. doi: 10.1038/nature08185 19571811
56. Winham S., et al. Genome-wide association study of bipolar disorder accounting for effect of body mass index identifies a new risk allele in TCF7L2. Molecular psychiatry, 2014. 19(9): p. 1010–1016. doi: 10.1038/mp.2013.159 24322204
57. Lei P., et al. Tau protein: relevance to Parkinson's disease. The international journal of biochemistry & cell biology, 2010. 42(11): p. 1775–1778.
58. Allen M., et al. Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels. Alzheimer's research & therapy, 2014. 6(4): p. 1.
59. Lu Q., et al. GenoWAP: GWAS signal prioritization through integrated analysis of genomic functional annotation. Bioinformatics, 2016. 32(4): p. 542–548. doi: 10.1093/bioinformatics/btv610 26504140
60. Draber P., et al. SCIMP, a transmembrane adaptor protein involved in major histocompatibility complex class II signaling. Molecular and cellular biology, 2011. 31(22): p. 4550–4562. doi: 10.1128/MCB.05817-11 21930792
61. Talwar P., et al. Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease. BMC genomics, 2014. 15(1): p. 1.
62. Desikan R.S., et al. Polygenic overlap between C-reactive protein, plasma lipids and Alzheimer's disease. Circulation, 2015: p. CIRCULATIONAHA. 115.015489.
63. Sheu K.-F., et al. A DLST genotype associated with reduced risk for Alzheimer’s disease. Neurology, 1999. 52(7): p. 1505–1505. 10227647
64. Davies G., et al. Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N= 53 949). Molecular psychiatry, 2015. 20(2): p. 183–192. doi: 10.1038/mp.2014.188 25644384
65. Shin S.-Y., et al. An atlas of genetic influences on human blood metabolites. Nature genetics, 2014. 46(6): p. 543–550. doi: 10.1038/ng.2982 24816252
66. Jiang S., et al. Trafficking regulation of proteins in Alzheimer’s disease. Molecular neurodegeneration, 2014. 9(1): p. 1.
67. Vardarajan B.N., et al. Identification of Alzheimer disease-associated variants in genes that regulate retromer function. Neurobiology of aging, 2012. 33(9): p. 2231. e15–2231. e30.
68. Jun G.R., et al. Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimer's & Dementia, 2017.
69. Jonsson T., et al. Variant of TREM2 associated with the risk of Alzheimer's disease. New England Journal of Medicine, 2013. 368(2): p. 107–116. doi: 10.1056/NEJMoa1211103 23150908
70. Guerreiro R., et al. TREM2 variants in Alzheimer's disease. New England Journal of Medicine, 2013. 368(2): p. 117–127. doi: 10.1056/NEJMoa1211851 23150934
71. Gagliano S.A., et al. Genomics implicates adaptive and innate immunity in Alzheimer's and Parkinson's diseases. Annals of Clinical and Translational Neurology, 2016. 3(12): p. 924–933. doi: 10.1002/acn3.369 28097204
72. Huang K.-l., et al. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease. Nat Neurosci advance online publication(2017).
73. Sarkar A.K., Ward L.D., Kellis M., Functional enrichments of disease variants across thousands of independent loci in eight diseases. BioRxiv, 2016: p. 048066.
74. Finucane H., et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. bioRxiv, 2017: p. 103069.
75. Shi H., Kichaev G., Pasaniuc B., Contrasting the genetic architecture of 30 complex traits from summary association data. The American Journal of Human Genetics, 2016. 99(1): p. 139–153. doi: 10.1016/j.ajhg.2016.05.013 27346688
76. Gamazon E.R., et al. A gene-based association method for mapping traits using reference transcriptome data. Nature genetics, 2015. 47(9): p. 1091–1098. doi: 10.1038/ng.3367 26258848
77. Gusev A., et al. Integrative approaches for large-scale transcriptome-wide association studies. Nature genetics, 2016.
78. Mancuso N., et al. Integrating Gene Expression with Summary Association Statistics to Identify Genes Associated with 30 Complex Traits. The American Journal of Human Genetics, 2017. 100(3): p. 473–487. doi: 10.1016/j.ajhg.2017.01.031 28238358
79. Ernst J., Kellis M., Large-scale imputation of epigenomic datasets for systematic annotation of diverse human tissues. Nature biotechnology, 2015. 33(4): p. 364–376. doi: 10.1038/nbt.3157 25690853
80. Consortium T.F., A promoter-level mammalian expression atlas. Nature, 2014. 507(7493): p. 462–470. doi: 10.1038/nature13182 24670764
81. Abecasis G.R., et al. An integrated map of genetic variation from 1,092 human genomes. Nature, 2012. 491(7422): p. 56–65. doi: 10.1038/nature11632 23128226
82. Yang J., et al. GCTA: a tool for genome-wide complex trait analysis. The American Journal of Human Genetics, 2011. 88(1): p. 76–82. doi: 10.1016/j.ajhg.2010.11.011 21167468
83. Willer C.J., Li Y., Abecasis G.R., METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics, 2010. 26(17): p. 2190–1. doi: 10.1093/bioinformatics/btq340 20616382
84. Reimand J., et al. g: Profiler—a web server for functional interpretation of gene lists (2016 update). Nucleic acids research, 2016: p. gkw199.
85. Pruim R.J., et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics, 2010. 26(18): p. 2336–2337. doi: 10.1093/bioinformatics/btq419 20634204